AI assistant
ELI LILLY & Co — Director's Dealing 2016
Feb 3, 2016
29745_dirs_2016-02-03_33266b7d-26b2-4cb7-a4b6-c604b25e4cbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-02-01
Reporting Person: Fry Stephen F (SVP, HR & Diversity)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-01 | Common Stock | M | 7252 | — | Acquired | 81467 | Direct |
| 2016-02-01 | Common Stock | F | 3410 | $79.10 | Disposed | 78057 | Direct |
| 2016-02-01 | Common Stock | S | 2412 | $78.39 | Disposed | 75645 | Direct |
| 2016-02-03 | Common Stock | S | 725 | $76.46 | Disposed | 74920 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-01 | Restricted Stock Unit | $ | M | 7252 | Disposed | 2016-02-01 | Common Stock (7252.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 159 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2015.
F2: This transaction was executed in multiple trades at prices ranging from $78.19 to $78.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.